Cited 101 times in
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.